Selected article for: "herd immunity and long term"

Author: Buonomo, Antonio; Morra, Vincenzo Brescia; Zappulo, Emanuela; Lanzillo, Roberta; Gentile, Ivan; Montella, Emma; Triassi, Maria; Palladino, Raffaele; Moccia, Marcello
Title: COVID-19 prevention and multiple sclerosis management: the SAFE pathway for the post-peak
  • Cord-id: 5b0hcy9t
  • Document date: 2020_6_10
  • ID: 5b0hcy9t
    Snippet: BACKGROUND: We hereby report on our experience from Naples (South Italy), where the peak of coronavirus disease 2019 (COVID-19) has already passed. METHODS: Assuming that COVID-19 will be circulating until vaccination and/or herd immunity is achieved (possibly not earlier than 2021), we have developed a protocol for the long-term management of multiple sclerosis (MS). RESULTS: We have defined a pathway for the access to the MS Centre with logistic, preventative and clinical recommendations, and
    Document: BACKGROUND: We hereby report on our experience from Naples (South Italy), where the peak of coronavirus disease 2019 (COVID-19) has already passed. METHODS: Assuming that COVID-19 will be circulating until vaccination and/or herd immunity is achieved (possibly not earlier than 2021), we have developed a protocol for the long-term management of multiple sclerosis (MS). RESULTS: We have defined a pathway for the access to the MS Centre with logistic, preventative and clinical recommendations, and have also included 14-day self-isolation and COVID-19 testing before some disease modifying treatments. DISCUSSION: Overall, we believe our experience could be helpful for MS management in the upcoming months.

    Search related documents:
    Co phrase search for related documents
    • access time and local service: 1
    • active infection and lymphocyte count: 1, 2, 3